Lupin Pharmaceuticals Brings New Opportunities to Right to Work Florida
Lupin Pharmaceuticals is investing a total of $250 million in order to expand its current operations in Right to Work Coral Springs, Florida. As a result, the company will also create over 200 new job opportunities in the area!
From Area Development Magazine:
“The expansion of Lupin’s footprint in Coral Springs is a core part of our growth strategy. This new state-of-the-art facility will build on our existing presence in Florida, which is home to Lupin’s headquarters and our Advanced Inhalation Research Center. This investment demonstrates Lupin’s commitment to innovation, quality and supply chain reliability — and our ability to partner with Florida’s leaders to strengthen America’s medicine security by growing our capacity to produce affordable treatments for patients. We are grateful to Florida’s leadership for their partnership in making this possible.” […]
“On behalf of FloridaCommerce, I’m excited to welcome Lupin’s expansion in Coral Springs and the high-impact investment it brings to our state. […] Thanks to Governor DeSantis’ leadership, Florida has built a strong foundation for growth—with a strong focus on research and development, nine consecutive years as the #1 state for postsecondary education and three consecutive years as the #1 state for talent development, Florida has become #2 in the nation for both pharmaceutical and medical device manufacturing. Lupin’s investment will strengthen Florida’s position as a leader in life sciences, boost our advanced manufacturing capabilities and enhance the state’s medicine security—delivering long-term benefits to both our economy and the health of Floridians.”
To read the previous economic update on Right to Work states, click here.